Belite Bio Inc Statistics
Share Statistics
Belite Bio Inc has 30.88M shares outstanding. The number of shares has increased by 3.78% in one year.
| Shares Outstanding | 30.88M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.87% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 12.70M |
| Failed to Deliver (FTD) Shares | 396 |
| FTD / Avg. Volume | 0.54% |
Short Selling Information
The latest short interest is 202.32K, so 0.66% of the outstanding shares have been sold short.
| Short Interest | 202.32K |
| Short % of Shares Out | 0.66% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 2.67 |
Valuation Ratios
The PE ratio is -38.46 and the forward PE ratio is -84.53.
| PE Ratio | -38.46 |
| Forward PE | -84.53 |
| PS Ratio | 0 |
| Forward PS | 30.4 |
| PB Ratio | 13.45 |
| P/FCF Ratio | -40.69 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Belite Bio Inc.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.76, with a Debt / Equity ratio of 0.
| Current Ratio | 24.76 |
| Quick Ratio | 24.76 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -1266.72 |
Financial Efficiency
Return on equity (ROE) is -0.35% and return on capital (ROIC) is -34.69%.
| Return on Equity (ROE) | -0.35% |
| Return on Assets (ROA) | -0.33% |
| Return on Capital (ROIC) | -34.69% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.58M |
| Employee Count | 20 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 9.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 19.72% in the last 52 weeks. The beta is -1.6, so Belite Bio Inc's price volatility has been lower than the market average.
| Beta | -1.6 |
| 52-Week Price Change | 19.72% |
| 50-Day Moving Average | 68.45 |
| 200-Day Moving Average | 52.76 |
| Relative Strength Index (RSI) | 30.78 |
| Average Volume (20 Days) | 73.39K |
Income Statement
| Revenue | n/a |
| Gross Profit | -399.00K |
| Operating Income | -31.67M |
| Net Income | -31.63M |
| EBITDA | -31.53M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.19 |
Balance Sheet
The company has 88.16M in cash and 886.00K in debt, giving a net cash position of 87.27M.
| Cash & Cash Equivalents | 88.16M |
| Total Debt | 886.00K |
| Net Cash | 87.27M |
| Retained Earnings | -71.50M |
| Total Assets | 115.82M |
| Working Capital | 111.27M |
Cash Flow
In the last 12 months, operating cash flow was -29.84M and capital expenditures -63.00K, giving a free cash flow of -29.90M.
| Operating Cash Flow | -29.84M |
| Capital Expenditures | -63.00K |
| Free Cash Flow | -29.90M |
| FCF Per Share | -1.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BLTE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.16% |
| FCF Yield | -1.76% |
Analyst Forecast
The average price target for BLTE is $100, which is 81.8% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $100 |
| Price Target Difference | 81.8% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 300.59 |
| Piotroski F-Score | 1 |